INSE
Inspired Entertainment, Inc.
INSE has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over INSE overall, supported by stronger fundamentals and stronger modeled upside.
INSE Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Healthy | |
| Under pressure |
INSE's cash flow is currently healthy, and its profitability is stable, but its revenue and balance sheet are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
INSE PE Valuation
INSE has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
INSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| High |
Analysts expect INSE's earnings and revenue to decline, with profitability weakening.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
INSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.25 | -113% |
| Q2 2026 | -$0.32 | -115% |
| Q1 2026 | -$0.60 | -125% |
| Q4 2025 | -$0.58 | -126% |
| Q3 2025 | $1.89 | +$1.90 |
| Q2 2025 | $2.08 | +$2.09 |
| Q1 2025 | $2.42 | +2100% |
| Q4 2024 | $2.22 | +754% |
INSE has swung to a loss: it lost $0.25 per share over the past year, after a profit the year before.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over INSE on earnings, with more consistent year-over-year improvement.
INSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $61.4M | -29% |
| Q2 2026 | $60.8M | -24% |
| Q1 2026 | $57.2M | -5.3% |
| Q4 2025 | $77.2M | -4% |
| Q3 2025 | $86.2M | +11% |
| Q2 2025 | $80.3M | +6.2% |
| Q1 2025 | $60.4M | -4.3% |
| Q4 2024 | $80.4M | -1% |
INSE's revenue has slid since its 2023 peak: $61M last quarter, down 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +5.5 points |
| Q2 2026 | 16% | +6.4 points |
| Q1 2026 | 16% | +13 points |
| Q4 2025 | 15% | +1.2 points |
| Q3 2025 | 11% | -4 points |
| Q2 2025 | 9.8% | -2.6 points |
| Q1 2025 | 2.6% | +4.9 points |
| Q4 2024 | 13% | +2 points |
INSE has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over INSE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
INSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16.4M | +281% |
| Q2 2026 | $100K | -98% |
| Q1 2026 | $23M | +41% |
| Q4 2025 | -$9.9M | -719% |
| Q3 2025 | $4.3M | -81% |
| Q2 2025 | $5.6M | +$14.2M |
| Q1 2025 | $16.3M | +$17.1M |
| Q4 2024 | $1.6M | +$4.1M |
INSE has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
INSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -595K shares |
| 1 year | -1.4% | -413K shares |
| 3 years | -1.5% | -423K shares |
| 5 years | +11% | +2.9M shares |
| Available history | +31% | +6.8M shares |
INSE has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.6M |
| Q1 2026 | $2.6M |
| Q4 2023 | — |
| Q3 2023 | $1.5M |
| Q4 2022 | $400,000 |
| Q3 2022 | $4.9M |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
INSE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.8x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.8x | Elevated |
INSE's net debt is about 3.0 years of its operating earnings (EBITDA), down from 3.8 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 21.2 | Neutral |
INSE's weekly RSI is 40 (neutral) and its Stochastic is 21 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
INSE PE vs Consumer Cyclical Sector
| Metric | INSE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
INSE has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
INSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.74 | 17% above |
| 20 week MA | $5.26 | 17% below |
| 50 week MA | $6.90 | 36% below |
| 100 week MA | $7.76 | 43% below |
| 200 week MA | $9.31 | 53% below |
INSE has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
INSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.90 | $6.84 | -0.9% |
| 2021 | $6.84 | $12.2 | +78% |
| 2022 | $12.2 | $12.9 | +5.9% |
| 2023 | $12.9 | $9.88 | -23% |
| 2024 | $9.88 | $8.90 | -9.9% |
| 2025 | $8.90 | $9.51 | +6.9% |
| 2026 YTD | $9.51 | $4.39 | -54% |
INSE has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.